Cargando…

How should individual participant data (IPD) from publicly funded clinical trials be shared?

BACKGROUND: Individual participant data (IPD) from completed clinical trials should be responsibly shared to support efficient clinical research, generate new knowledge and bring benefit to patients. The Medical Research Council (MRC) Hubs for Trials Methodology Research (HTMR) has developed guidanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tudur Smith, C., Hopkins, C., Sydes, M. R., Woolfall, K., Clarke, M., Murray, G., Williamson, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682216/
https://www.ncbi.nlm.nih.gov/pubmed/26675031
http://dx.doi.org/10.1186/s12916-015-0532-z
_version_ 1782405858504736768
author Tudur Smith, C.
Hopkins, C.
Sydes, M. R.
Woolfall, K.
Clarke, M.
Murray, G.
Williamson, P.
author_facet Tudur Smith, C.
Hopkins, C.
Sydes, M. R.
Woolfall, K.
Clarke, M.
Murray, G.
Williamson, P.
author_sort Tudur Smith, C.
collection PubMed
description BACKGROUND: Individual participant data (IPD) from completed clinical trials should be responsibly shared to support efficient clinical research, generate new knowledge and bring benefit to patients. The Medical Research Council (MRC) Hubs for Trials Methodology Research (HTMR) has developed guidance to facilitate the sharing of IPD from publicly funded clinical trials. METHODS: Development of the guidance was completed over four phases which included a focussed review of policy documents, a web-based survey of the UK Clinical Research Collaboration (CRC) Registered Clinical Trials Units (CTU) Network, participation of an expert committee and an open consultation with the UKCRC Registered CTU Network. The project was funded by the MRC HTMR (MR/L004933/1-R39). RESULTS: Good practice principles include: (i) the use of a controlled access approach, using a transparent and robust system to review requests and provide secure data access; (ii) seeking consent for sharing IPD from trial participants in all future clinical trials with adequate assurance that patient privacy and confidentiality can be maintained; and (iii) establishing an approach to resource the sharing of IPD which would include support from trial funders, sponsor organisations and users of IPD. The guidance has been endorsed by Cancer Research UK, MRC Methodology Research Programme Advisory Group, Wellcome Trust and the Executive Group of the UKCRC Registered CTU Network. The National Institute for Health Research (NIHR) has confirmed it is supportive of the application of this guidance. CONCLUSIONS: Implementation of these principles will improve transparency, increase the coherent sharing of IPD from publicly funded trials, and help publicly funded trials to adhere to trial funder and journal requirements for data sharing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-015-0532-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4682216
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46822162015-12-18 How should individual participant data (IPD) from publicly funded clinical trials be shared? Tudur Smith, C. Hopkins, C. Sydes, M. R. Woolfall, K. Clarke, M. Murray, G. Williamson, P. BMC Med Guideline BACKGROUND: Individual participant data (IPD) from completed clinical trials should be responsibly shared to support efficient clinical research, generate new knowledge and bring benefit to patients. The Medical Research Council (MRC) Hubs for Trials Methodology Research (HTMR) has developed guidance to facilitate the sharing of IPD from publicly funded clinical trials. METHODS: Development of the guidance was completed over four phases which included a focussed review of policy documents, a web-based survey of the UK Clinical Research Collaboration (CRC) Registered Clinical Trials Units (CTU) Network, participation of an expert committee and an open consultation with the UKCRC Registered CTU Network. The project was funded by the MRC HTMR (MR/L004933/1-R39). RESULTS: Good practice principles include: (i) the use of a controlled access approach, using a transparent and robust system to review requests and provide secure data access; (ii) seeking consent for sharing IPD from trial participants in all future clinical trials with adequate assurance that patient privacy and confidentiality can be maintained; and (iii) establishing an approach to resource the sharing of IPD which would include support from trial funders, sponsor organisations and users of IPD. The guidance has been endorsed by Cancer Research UK, MRC Methodology Research Programme Advisory Group, Wellcome Trust and the Executive Group of the UKCRC Registered CTU Network. The National Institute for Health Research (NIHR) has confirmed it is supportive of the application of this guidance. CONCLUSIONS: Implementation of these principles will improve transparency, increase the coherent sharing of IPD from publicly funded trials, and help publicly funded trials to adhere to trial funder and journal requirements for data sharing. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12916-015-0532-z) contains supplementary material, which is available to authorized users. BioMed Central 2015-12-17 /pmc/articles/PMC4682216/ /pubmed/26675031 http://dx.doi.org/10.1186/s12916-015-0532-z Text en © Tudur Smith et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Guideline
Tudur Smith, C.
Hopkins, C.
Sydes, M. R.
Woolfall, K.
Clarke, M.
Murray, G.
Williamson, P.
How should individual participant data (IPD) from publicly funded clinical trials be shared?
title How should individual participant data (IPD) from publicly funded clinical trials be shared?
title_full How should individual participant data (IPD) from publicly funded clinical trials be shared?
title_fullStr How should individual participant data (IPD) from publicly funded clinical trials be shared?
title_full_unstemmed How should individual participant data (IPD) from publicly funded clinical trials be shared?
title_short How should individual participant data (IPD) from publicly funded clinical trials be shared?
title_sort how should individual participant data (ipd) from publicly funded clinical trials be shared?
topic Guideline
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4682216/
https://www.ncbi.nlm.nih.gov/pubmed/26675031
http://dx.doi.org/10.1186/s12916-015-0532-z
work_keys_str_mv AT tudursmithc howshouldindividualparticipantdataipdfrompubliclyfundedclinicaltrialsbeshared
AT hopkinsc howshouldindividualparticipantdataipdfrompubliclyfundedclinicaltrialsbeshared
AT sydesmr howshouldindividualparticipantdataipdfrompubliclyfundedclinicaltrialsbeshared
AT woolfallk howshouldindividualparticipantdataipdfrompubliclyfundedclinicaltrialsbeshared
AT clarkem howshouldindividualparticipantdataipdfrompubliclyfundedclinicaltrialsbeshared
AT murrayg howshouldindividualparticipantdataipdfrompubliclyfundedclinicaltrialsbeshared
AT williamsonp howshouldindividualparticipantdataipdfrompubliclyfundedclinicaltrialsbeshared